Peridialytic Erythropoietin versus Roxadustat in Hemodialysis-Dependent Chronic Kidney Disease Patients
American Journal of Nephrology · 2025
DOI: 10.1159/000546158 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift American Journal of Nephrology, 2025. Verfasst von Lihua Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kidney Disease and Blood Purification Centre, 2nd Hospital of Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Renal Dialysis, Anemia, Glycine, Renal Insufficiency, Chronic. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Introduction
Erythropoietin and roxadustat are commonly used to manage anemia in hemodialysis-dependent chronic kidney disease (CKD) patients, but the comparative safety and effectiveness are unknown.
Methods
This is a retrospective cohort study. Data were extracted from Tianjin Healthcare and Medical Big Data Platform. We screened all patients with CKD stage G5 and anemia (hemoglobin
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Kidney Disease and Blood Purification Centre, 2nd Hospital of Tianjin Medical University, Tianjin, China.
- Division of Nephrology, Department of Medicine, Shanghai First People Hospital, Jiao Tong University School of Medicine, Shanghai, China.
- Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Nephrology, The First Hospital of China Medical University, Shenyang, China.
- Division of Nephrology, Kidney Institute of PLA, Changzheng Hospital, Naval Medical University, Shanghai, China.
- Division of Nephrology, Kidney Institute of PLA, Changzheng Hospital, Naval Medical University, Shanghai, China, chlmei1954@126.com.
Zitieren
APA
Wang, L., Cao, Y., Yuan, W., Hao, C., Yao, L., Xue, C., Yu, P., & Mei, C. (2025). Peridialytic Erythropoietin versus Roxadustat in Hemodialysis-Dependent Chronic Kidney Disease Patients. American Journal of Nephrology. https://doi.org/10.1159/000546158
Vancouver
Wang L, Cao Y, Yuan W, Hao C, Yao L, Xue C, et al. Peridialytic Erythropoietin versus Roxadustat in Hemodialysis-Dependent Chronic Kidney Disease Patients. American Journal of Nephrology. 2025. doi:10.1159/000546158
BibTeX
@article{Wang2025,
author = {Wang, Lihua and Cao, Yueqi and Yuan, Weijie and Hao, Chuanming and Yao, Li and Xue, Cheng and Yu, Pei and Mei, Changlin},
title = {Peridialytic Erythropoietin versus Roxadustat in Hemodialysis-Dependent Chronic Kidney Disease Patients},
journal = {American Journal of Nephrology},
year = {2025},
doi = {10.1159/000546158}
}
EUVIMED